Please tell us about your clinical experience. How many bronchoscopic biopsies do you undertake on a yearly basis? What percent of them have inconclusive results? What is the most common reason for this? 

How hard is it to perform the biopsy procedure when it involves finding nodules in the peripheral lung?

What % of total biopsies have to be done far into the peripheral lung? What % of cases require finding nodules outside airways? And how hard are those procedures to perform without a robotic assisted device?

How does Ion compare to manual techniques or ENB technology, in regards to 180 degrees articulation in any direction, airway generation access, and tip deflection correction?

How important is the ability to repeatedly biopsy the same target, real time confirmation of a representative tissue sample and changing the sample location in the same area, that the Ion device provides?

Have you seen an increased rate of adoption of robotic assisted biopsies performed by clinicians recently?

How has COVID-19 influenced the detection procedures in mild to serious cases? Has there been a change in the number of biopsies performed?